Navigation Links
Body heat, fermentation drive new drug-delivery 'micropump'

WEST LAFAYETTE, Ind. Researchers have created a new type of miniature pump activated by body heat that could be used in drug-delivery patches powered by fermentation.

The micropump contains bakers yeast and sugar in a small chamber. When water is added and the patch is placed on the skin, the body heat and the added water causes the yeast and sugar to ferment, generating a small amount of carbon dioxide gas. The gas pushes against a membrane and has been shown to continually pump for several hours, said Babak Ziaie, a Purdue University professor of electrical and computer engineering and biomedical engineering.

Such miniature pumps could make possible drug-delivery patches that use arrays of "microneedles" to deliver a wider range of medications than now possible with conventional patches. Unlike many other micropumps under development or in commercial use, the new technology requires no batteries, said Ziaie, who is working with doctoral student Manuel Ochoa.

"This just needs yeast, sugar, water and your own body heat," Ziaie said.

The robustness of yeast allows for long shelf life, and the design is ideal for mass production, Ochoa said.

"It would be easy to fabricate because it's just a few layers of polymers sandwiched together and bonded," he said.

Findings were detailed in a research paper published online in August in the journal Lab on a Chip. The paper was written by Ochoa and Ziaie, and the research is based at Purdue's Birck Nanotechnology Center in the university's Discovery Park.

The "the microorganism-powered thermopneumatic pump" is made out of layers of a rubberlike polymer, called polydimethylsiloxane, which is used commercially for diaphragms in pumps. The prototype is 1.5 centimeters long.

Current "transdermal" patches are limited to delivering drugs that, like nicotine, are made of small hydrophobic molecules that can be absorbed through the skin, Ziaie said.

"Many drugs, including those for treating cancer and autoimmune disorders cannot be delivered with patches because they are large molecules that won't go through the skin," he said. "Although transdermal drug delivery via microneedle arrays has long been identified as a viable and promising method for delivering large hydrophilic molecules across the skin, a suitable pump has been hard to develop."

Patches that used arrays of tiny microneedles could deliver a multitude of drugs, and the needles do not cause pain because they barely penetrate the skin, Ziaie said. The patches require a pump to push the drugs through the narrow needles, which have a diameter of about 20 microns, or roughly one-fourth as wide as a human hair.

Most pumps proposed for drug-delivery applications rely on an on-board power source, which is bulky, costly and requires complex power-management circuits to conserve battery life. "Our approach is much more simple," Ziaie said. "It could be a disposable transdermal pump. You just inject water into the patch and place it on your skin. After it's used up, you would through it away."

Researchers have filed an application for a provisional patent on the device.


Contact: Emil Venere
Purdue University

Related biology news :

1. An early spring drives butterfly population declines
2. To drive infections, a hijacking virus mimics a cells signaling system
3. New Center for Carbon Measurement to drive UKs low carbon economy
4. Global Surgical Devices Market Growth Driven by Improving Standards of Living and Longer Life Expectancies, Research Shows
5. Thomson Reuters Launches Life Sciences Partner Ecosystem to Drive Collaborative R&D Drug Processes
6. Global warming has driven Europes mountain plants to migrate 2.7 meters upwards in 7 years
7. Medical device, health professionals attend first national conference on value-driven engineering
8. The academic jungle: Ecosystem model reveals why women are driven out of science
9. TLR1 protein drives immune response to certain food-borne illness in mice
10. Drivers of marine biodiversity: Tiny, freeloading clams find the key to evolutionary success
Post Your Comments:
Related Image:
Body heat, fermentation drive new drug-delivery 'micropump'
(Date:4/26/2016)... and LONDON , April 26, ... of EdgeVerve Systems, a product subsidiary of Infosys ... announced a partnership to integrate the Onegini mobile ...      (Logo: ) ... customers enhanced security to access and transact across ...
(Date:4/14/2016)... Israel , April 14, 2016 ... Authentication and Malware Detection, today announced the appointment of ... assumed the new role. Goldwerger,s leadership appointment ... on the heels of the deployment of its platform ... BioCatch,s behavioral biometric technology, which discerns unique cognitive and ...
(Date:3/23/2016)... 23, 2016 ... Gesichts- und Stimmerkennung mit Passwörtern     ... MESG ), ein führender Anbieter digitaler ... mit SpeechPro zusammenarbeitet, um erstmals dessen Biometrietechnologie ... die Möglichkeit angeboten, im Rahmen mobiler Apps ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... -- Global demand for enzymes is forecast to grow ... billion.  This market includes enzymes used in industrial ... animal feed, and other markets) and specialty applications ... beverages will remain the largest market for enzymes, ... containing enzymes in developing regions.  These and other ...
(Date:6/27/2016)... ... ... Parallel 6 , the leading software as a service (SaaS) provider ... Patient Encounter CONSULT module which enables both audio and video telemedicine communication between the ... the CONSULT module, patients and physicians can schedule a face to face virtual patient ...
(Date:6/27/2016)... , June 27, 2016   Ginkgo Bioworks , ... industrial engineering, was today awarded as one of ... of the world,s most innovative companies. Ginkgo Bioworks ... for the real world in the nutrition, health ... work directly with customers including Fortune 500 companies ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle Marche in ... peritoneal or pleural mesothelioma. Their findings are the subject of a new article on ... biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma patients that ...
Breaking Biology Technology: